{
    "Trade/Device Name(s)": [
        "VITROS\u00ae Automation Solutions"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K160495",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063144"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KLI",
        "JJE",
        "KLT",
        "LCD"
    ],
    "Summary Letter Date": "August 19, 2016",
    "Summary Letter Received Date": "August 22, 2016",
    "Submission Date": "October 6, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.1700",
        "862.3645",
        "862.3450",
        "862.2160"
    ],
    "Regulation Name(s)": [
        "Total thyroxine test system",
        "Carbamazepine test system",
        "Gentamicin test system",
        "Discrete photometric chemistry analyzers for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Total thyroxine (T4)",
        "Carbamazepine",
        "Gentamicin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITROS\u00ae Systems",
        "VITROS\u00ae 5,1 FS Chemistry System",
        "VITROS\u00ae 4600 Chemistry System",
        "VITROS\u00ae 3600 Immunodiagnostics Systems",
        "VITROS\u00ae 5600 Integrated Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Automated laboratory sample processing",
        "Point-in-space pipetting",
        "Robotic interface module",
        "Photometric chemistry",
        "Immunodiagnostics"
    ],
    "Methodologies": [
        "Automation of pre-analytical and post-analytical sample processing"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Software",
        "Accessory",
        "Component",
        "Platform"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS\u00ae Automation Solutions laboratory automation system for clinical chemistry and toxicology analytes processing.",
    "Indications for Use Summary": "Intended to automate pre-analytical and post-analytical sample processing in the clinical laboratory, consolidating software, automation modules, and clinical analyzers to perform assays including total thyroxine, carbamazepine, and gentamicin.",
    "fda_folder": "Clinical Chemistry"
}